APO Research
Talk to an analyst

APO RESEARCH · REPORT

SPECT and PET Radiopharmaceuticals

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global SPECT and PET Radiopharmaceuticals Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

23 December 2025196 pages

Choose your research edition.

Industry ResearchSPECT and PET Radiopharmaceuticals Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal SPECT and PET Radiopharmaceuticals Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal SPECT and PET Radiopharmaceuticals Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal SPECT and PET Radiopharmaceuticals Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal SPECT and PET Radiopharmaceuticals Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global SPECT and PET Radiopharmaceuticals market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for SPECT and PET Radiopharmaceuticals is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for SPECT and PET Radiopharmaceuticals is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for SPECT and PET Radiopharmaceuticals is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for SPECT and PET Radiopharmaceuticals is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of SPECT and PET Radiopharmaceuticals include China Isotope & Radiation, Novartis, Eli Lilly, Dongcheng, Bayer, SIEMENS, Mundipharma, Lantheus and Jubilant Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global SPECT and PET Radiopharmaceuticals market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of SPECT and PET Radiopharmaceuticals and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents SPECT and PET Radiopharmaceuticals sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the SPECT and PET Radiopharmaceuticals market size, projected growth trends, production technologies, key applications, and end-use industries.

SPECT and PET Radiopharmaceuticals Segment by Company

China Isotope & Radiation

Novartis

Eli Lilly

Dongcheng

Bayer

SIEMENS

Mundipharma

Lantheus

Jubilant Pharma

GE Healthcare

Curium Pharma

Cardinal Health

Bracco Imaging

Aurobindo Pharma

SPECT and PET Radiopharmaceuticals Segment by Type

Diagnostic Radiopharmaceuticals

Therapeutic Radiopharmaceuticals

SPECT and PET Radiopharmaceuticals Segment by Application

Hospitals

Clinics

Others

SPECT and PET Radiopharmaceuticals Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global SPECT and PET Radiopharmaceuticals market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of SPECT and PET Radiopharmaceuticals and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of SPECT and PET Radiopharmaceuticals.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the SPECT and PET Radiopharmaceuticals market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of SPECT and PET Radiopharmaceuticals manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of SPECT and PET Radiopharmaceuticals in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of SPECT and PET Radiopharmaceuticals in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. SPECT and PET Radiopharmaceuticals Industry Trends Table 2. SPECT and PET Radiopharmaceuticals Industry Drivers Table 3. SPECT and PET Radiopharmaceuticals Industry Opportunities and Challenges Table 4. SPECT and PET Radiopharmaceuticals Industry Restraints Table 5. Global SPECT and PET Radiopharmaceuticals Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global SPECT and PET Radiopharmaceuticals Revenue Market Share by Manufacturers (2021-2026) Table 7. Global SPECT and PET Radiopharmaceuticals Sales by Manufacturers (k units) & (2021-2026) Table 8. Global SPECT and PET Radiopharmaceuticals Sales Market Share by Manufacturers Table 9. Global SPECT and PET Radiopharmaceuticals Average Sales Price (USD/unit) of Manufacturers (2021-2026) Table 10. Global SPECT and PET Radiopharmaceuticals Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global SPECT and PET Radiopharmaceuticals Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global SPECT and PET Radiopharmaceuticals Manufacturers, Product Type & Application Table 13. Global SPECT and PET Radiopharmaceuticals Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global SPECT and PET Radiopharmaceuticals by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Diagnostic Radiopharmaceuticals Table 17. Major Manufacturers of Therapeutic Radiopharmaceuticals Table 18. Global SPECT and PET Radiopharmaceuticals Sales by Type 2021 VS 2025 VS 2032 (k units) Table 19. Global SPECT and PET Radiopharmaceuticals Sales by Type (2021-2026) & (k units) Table 20. Global SPECT and PET Radiopharmaceuticals Sales by Type (2027-2032) & (k units) Table 21. Global SPECT and PET Radiopharmaceuticals Sales Market Share by Type (2021-2026) Table 22. Global SPECT and PET Radiopharmaceuticals Sales Market Share by Type (2027-2032) Table 23. Global SPECT and PET Radiopharmaceuticals Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 24. Global SPECT and PET Radiopharmaceuticals Revenue by Type (2021-2026) & (k units) Table 25. Global SPECT and PET Radiopharmaceuticals Revenue by Type (2027-2032) & (k units) Table 26. Global SPECT and PET Radiopharmaceuticals Revenue Market Share by Type (2021-2026) Table 27. Global SPECT and PET Radiopharmaceuticals Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Hospitals Table 29. Major Manufacturers of Clinics Table 30. Major Manufacturers of Others Table 31. Global SPECT and PET Radiopharmaceuticals Sales by Application 2021 VS 2025 VS 2032 (k units) Table 32. Global SPECT and PET Radiopharmaceuticals Sales by Application (2021-2026) & (k units) Table 33. Global SPECT and PET Radiopharmaceuticals Sales by Application (2027-2032) & (k units) Table 34. Global SPECT and PET Radiopharmaceuticals Sales Market Share by Application (2021-2026) Table 35. Global SPECT and PET Radiopharmaceuticals Sales Market Share by Application (2027-2032) Table 36. Global SPECT and PET Radiopharmaceuticals Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 37. Global SPECT and PET Radiopharmaceuticals Revenue by Application (2021-2026) & (k units) Table 38. Global SPECT and PET Radiopharmaceuticals Revenue by Application (2027-2032) & (k units) Table 39. Global SPECT and PET Radiopharmaceuticals Revenue Market Share by Application (2021-2026) Table 40. Global SPECT and PET Radiopharmaceuticals Revenue Market Share by Application (2027-2032) Table 41. Global SPECT and PET Radiopharmaceuticals Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 42. Global SPECT and PET Radiopharmaceuticals Sales by Region (2021-2026) & (k units) Table 43. Global SPECT and PET Radiopharmaceuticals Sales Market Share by Region (2021-2026) Table 44. Global SPECT and PET Radiopharmaceuticals Sales Forecasted by Region (2027-2032) & (k units) Table 45. Global SPECT and PET Radiopharmaceuticals Sales Forecasted Market Share by Region (2027-2032) Table 46. North America SPECT and PET Radiopharmaceuticals Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 47. North America SPECT and PET Radiopharmaceuticals Sales by Country (2021-2026) & (k units) Table 48. North America SPECT and PET Radiopharmaceuticals Sales by Country (2027-2032) & (k units) Table 49. Europe SPECT and PET Radiopharmaceuticals Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 50. Europe SPECT and PET Radiopharmaceuticals Sales by Country (2021-2026) & (k units) Table 51. Europe SPECT and PET Radiopharmaceuticals Sales by Country (2027-2032) & (k units) Table 52. Asia Pacific SPECT and PET Radiopharmaceuticals Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 53. Asia Pacific SPECT and PET Radiopharmaceuticals Sales by Country (2021-2026) & (k units) Table 54. Asia Pacific SPECT and PET Radiopharmaceuticals Sales by Country (2027-2032) & (k units) Table 55. South America, Middle East and Africa SPECT and PET Radiopharmaceuticals Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 56. South America, Middle East and Africa SPECT and PET Radiopharmaceuticals Sales by Country (2021-2026) & (k units) Table 57. South America, Middle East and Africa SPECT and PET Radiopharmaceuticals Sales by Country (2027-2032) & (k units) Table 58. Global SPECT and PET Radiopharmaceuticals Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global SPECT and PET Radiopharmaceuticals Revenue by Region (2021-2026) & (US$ Million) Table 60. Global SPECT and PET Radiopharmaceuticals Revenue by Region (2027-2032) & (US$ Million) Table 61. Global SPECT and PET Radiopharmaceuticals Revenue Market Share by Region (2021-2026) Table 62. Global SPECT and PET Radiopharmaceuticals Revenue Market Share by Region (2027-2032) Table 63. China Isotope & Radiation Company Information Table 64. China Isotope & Radiation Business Overview Table 65. China Isotope & Radiation SPECT and PET Radiopharmaceuticals Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. China Isotope & Radiation SPECT and PET Radiopharmaceuticals Product Portfolio Table 67. China Isotope & Radiation Recent Development Table 68. Novartis Company Information Table 69. Novartis Business Overview Table 70. Novartis SPECT and PET Radiopharmaceuticals Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Novartis SPECT and PET Radiopharmaceuticals Product Portfolio Table 72. Novartis Recent Development Table 73. Eli Lilly Company Information Table 74. Eli Lilly Business Overview Table 75. Eli Lilly SPECT and PET Radiopharmaceuticals Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Eli Lilly SPECT and PET Radiopharmaceuticals Product Portfolio Table 77. Eli Lilly Recent Development Table 78. Dongcheng Company Information Table 79. Dongcheng Business Overview Table 80. Dongcheng SPECT and PET Radiopharmaceuticals Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Dongcheng SPECT and PET Radiopharmaceuticals Product Portfolio Table 82. Dongcheng Recent Development Table 83. Bayer Company Information Table 84. Bayer Business Overview Table 85. Bayer SPECT and PET Radiopharmaceuticals Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Bayer SPECT and PET Radiopharmaceuticals Product Portfolio Table 87. Bayer Recent Development Table 88. SIEMENS Company Information Table 89. SIEMENS Business Overview Table 90. SIEMENS SPECT and PET Radiopharmaceuticals Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. SIEMENS SPECT and PET Radiopharmaceuticals Product Portfolio Table 92. SIEMENS Recent Development Table 93. Mundipharma Company Information Table 94. Mundipharma Business Overview Table 95. Mundipharma SPECT and PET Radiopharmaceuticals Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Mundipharma SPECT and PET Radiopharmaceuticals Product Portfolio Table 97. Mundipharma Recent Development Table 98. Lantheus Company Information Table 99. Lantheus Business Overview Table 100. Lantheus SPECT and PET Radiopharmaceuticals Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Lantheus SPECT and PET Radiopharmaceuticals Product Portfolio Table 102. Lantheus Recent Development Table 103. Jubilant Pharma Company Information Table 104. Jubilant Pharma Business Overview Table 105. Jubilant Pharma SPECT and PET Radiopharmaceuticals Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Jubilant Pharma SPECT and PET Radiopharmaceuticals Product Portfolio Table 107. Jubilant Pharma Recent Development Table 108. GE Healthcare Company Information Table 109. GE Healthcare Business Overview Table 110. GE Healthcare SPECT and PET Radiopharmaceuticals Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. GE Healthcare SPECT and PET Radiopharmaceuticals Product Portfolio Table 112. GE Healthcare Recent Development Table 113. Curium Pharma Company Information Table 114. Curium Pharma Business Overview Table 115. Curium Pharma SPECT and PET Radiopharmaceuticals Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Curium Pharma SPECT and PET Radiopharmaceuticals Product Portfolio Table 117. Curium Pharma Recent Development Table 118. Cardinal Health Company Information Table 119. Cardinal Health Business Overview Table 120. Cardinal Health SPECT and PET Radiopharmaceuticals Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Cardinal Health SPECT and PET Radiopharmaceuticals Product Portfolio Table 122. Cardinal Health Recent Development Table 123. Bracco Imaging Company Information Table 124. Bracco Imaging Business Overview Table 125. Bracco Imaging SPECT and PET Radiopharmaceuticals Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. Bracco Imaging SPECT and PET Radiopharmaceuticals Product Portfolio Table 127. Bracco Imaging Recent Development Table 128. Aurobindo Pharma Company Information Table 129. Aurobindo Pharma Business Overview Table 130. Aurobindo Pharma SPECT and PET Radiopharmaceuticals Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 131. Aurobindo Pharma SPECT and PET Radiopharmaceuticals Product Portfolio Table 132. Aurobindo Pharma Recent Development Table 133. Key Raw Materials Table 134. Raw Materials Key Suppliers Table 135. SPECT and PET Radiopharmaceuticals Distributors List Table 136. SPECT and PET Radiopharmaceuticals Customers List Table 137. Research Programs/Design for This Report Table 138. Authors List of This Report Table 139. Secondary Sources Table 140. Primary Sources List of Figures Figure 1. SPECT and PET Radiopharmaceuticals Product Image Figure 2. Global SPECT and PET Radiopharmaceuticals Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global SPECT and PET Radiopharmaceuticals Market Size (2021-2032) & (US$ Million) Figure 4. Global SPECT and PET Radiopharmaceuticals Sales (2021-2032) & (k units) Figure 5. Global SPECT and PET Radiopharmaceuticals Average Price (USD/unit) & (2021-2032) Figure 6. Global Top 5 and 10 SPECT and PET Radiopharmaceuticals Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Diagnostic Radiopharmaceuticals Image Figure 9. Therapeutic Radiopharmaceuticals Image Figure 10. Global SPECT and PET Radiopharmaceuticals Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 11. Global SPECT and PET Radiopharmaceuticals Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global SPECT and PET Radiopharmaceuticals Sales Market Share by Type (2021-2032) Figure 13. Global SPECT and PET Radiopharmaceuticals Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global SPECT and PET Radiopharmaceuticals Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global SPECT and PET Radiopharmaceuticals Revenue Market Share by Type (2021-2032) Figure 16. Hospitals Image Figure 17. Clinics Image Figure 18. Others Image Figure 19. Global SPECT and PET Radiopharmaceuticals Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 20. Global SPECT and PET Radiopharmaceuticals Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global SPECT and PET Radiopharmaceuticals Sales Market Share by Application (2021-2032) Figure 22. Global SPECT and PET Radiopharmaceuticals Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 23. Global SPECT and PET Radiopharmaceuticals Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global SPECT and PET Radiopharmaceuticals Revenue Market Share by Application (2021-2032) Figure 25. North America SPECT and PET Radiopharmaceuticals Sales and Growth Rate (2021-2032) & (k units) Figure 26. North America SPECT and PET Radiopharmaceuticals Sales Market Share by Country (2021-2032) Figure 27. U.S. SPECT and PET Radiopharmaceuticals Sales and Growth Rate (2021-2032) & (k units) Figure 28. Canada SPECT and PET Radiopharmaceuticals Sales and Growth Rate (2021-2032) & (k units) Figure 29. Mexico SPECT and PET Radiopharmaceuticals Sales and Growth Rate (2021-2032) & (k units) Figure 30. Europe SPECT and PET Radiopharmaceuticals Sales and Growth Rate (2021-2032) & (k units) Figure 31. Europe SPECT and PET Radiopharmaceuticals Sales Market Share by Country (2021-2032) Figure 32. Germany SPECT and PET Radiopharmaceuticals Sales and Growth Rate (2021-2032) & (k units) Figure 33. France SPECT and PET Radiopharmaceuticals Sales and Growth Rate (2021-2032) & (k units) Figure 34. U.K. SPECT and PET Radiopharmaceuticals Sales and Growth Rate (2021-2032) & (k units) Figure 35. Italy SPECT and PET Radiopharmaceuticals Sales and Growth Rate (2021-2032) & (k units) Figure 36. Netherlands SPECT and PET Radiopharmaceuticals Sales and Growth Rate (2021-2032) & (k units) Figure 37. Asia Pacific SPECT and PET Radiopharmaceuticals Sales and Growth Rate (2021-2032) & (k units) Figure 38. Asia Pacific SPECT and PET Radiopharmaceuticals Sales Market Share by Country (2021-2032) Figure 39. China SPECT and PET Radiopharmaceuticals Sales and Growth Rate (2021-2032) & (k units) Figure 40. Japan SPECT and PET Radiopharmaceuticals Sales and Growth Rate (2021-2032) & (k units) Figure 41. South Korea SPECT and PET Radiopharmaceuticals Sales and Growth Rate (2021-2032) & (k units) Figure 42. Southeast Asia SPECT and PET Radiopharmaceuticals Sales and Growth Rate (2021-2032) & (k units) Figure 43. India SPECT and PET Radiopharmaceuticals Sales and Growth Rate (2021-2032) & (k units) Figure 44. Australia SPECT and PET Radiopharmaceuticals Sales and Growth Rate (2021-2032) & (k units) Figure 45. South America, Middle East and Africa SPECT and PET Radiopharmaceuticals Sales and Growth Rate (2021-2032) & (k units) Figure 46. South America, Middle East and Africa SPECT and PET Radiopharmaceuticals Sales Market Share by Country (2021-2032) Figure 47. Brazil SPECT and PET Radiopharmaceuticals Sales and Growth Rate (2021-2032) & (k units) Figure 48. South Africa SPECT and PET Radiopharmaceuticals Sales and Growth Rate (2021-2032) & (k units) Figure 49. Saudi Arabia SPECT and PET Radiopharmaceuticals Sales and Growth Rate (2021-2032) & (k units) Figure 50. Turkey SPECT and PET Radiopharmaceuticals Sales and Growth Rate (2021-2032) & (k units) Figure 51. Argentina SPECT and PET Radiopharmaceuticals Sales and Growth Rate (2021-2032) & (k units) Figure 52. UAE SPECT and PET Radiopharmaceuticals Sales and Growth Rate (2021-2032) & (k units) Figure 53. Egypt SPECT and PET Radiopharmaceuticals Sales and Growth Rate (2021-2032) & (k units) Figure 54. Chile SPECT and PET Radiopharmaceuticals Sales and Growth Rate (2021-2032) & (k units) Figure 55. Global SPECT and PET Radiopharmaceuticals Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global SPECT and PET Radiopharmaceuticals Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America SPECT and PET Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Figure 58. North America SPECT and PET Radiopharmaceuticals Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe SPECT and PET Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Figure 60. Europe SPECT and PET Radiopharmaceuticals Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific SPECT and PET Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific SPECT and PET Radiopharmaceuticals Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa SPECT and PET Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa SPECT and PET Radiopharmaceuticals Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. SPECT and PET Radiopharmaceuticals Value Chain Figure 66. Manufacturing Cost Structure Figure 67. SPECT and PET Radiopharmaceuticals Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Diagnostic Radiopharmaceuticals
  • Therapeutic Radiopharmaceuticals
Applications
  • Hospitals
  • Clinics
  • Others
Companies covered
  • China Isotope & Radiation
  • Novartis
  • Eli Lilly
  • Dongcheng
  • Bayer
  • SIEMENS
  • Mundipharma
  • Lantheus
  • Jubilant Pharma
  • GE Healthcare
  • Curium Pharma
  • Cardinal Health
  • Bracco Imaging
  • Aurobindo Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global SPECT and PET Radiopharmaceuticals Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global SPECT and PET Radiopharmaceuticals Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global SPECT and PET Radiopharmaceuticals Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global SPECT and PET Radiopharmaceuticals Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global SPECT and PET Radiopharmaceuticals Market Dynamics
  1. 2.1 SPECT and PET Radiopharmaceuticals Industry Trends
  2. 2.2 SPECT and PET Radiopharmaceuticals Industry Drivers
  3. 2.3 SPECT and PET Radiopharmaceuticals Industry Opportunities and Challenges
  4. 2.4 SPECT and PET Radiopharmaceuticals Industry Restraints
3 SPECT and PET Radiopharmaceuticals Market by Manufacturers
  1. 3.1 Global SPECT and PET Radiopharmaceuticals Revenue by Manufacturers (2021-2026)
  2. 3.2 Global SPECT and PET Radiopharmaceuticals Sales by Manufacturers (2021-2026)
  3. 3.3 Global SPECT and PET Radiopharmaceuticals Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global SPECT and PET Radiopharmaceuticals Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global SPECT and PET Radiopharmaceuticals Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global SPECT and PET Radiopharmaceuticals Manufacturers, Product Type & Application
  7. 3.7 Global SPECT and PET Radiopharmaceuticals Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global SPECT and PET Radiopharmaceuticals Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 SPECT and PET Radiopharmaceuticals Players Market Share by Revenue in 2025
  11. 3.8.3 2025 SPECT and PET Radiopharmaceuticals Tier 1, Tier 2, and Tier 3
4 SPECT and PET Radiopharmaceuticals Market by Type
  1. 4.1 SPECT and PET Radiopharmaceuticals Type Introduction
  2. 4.1.1 Diagnostic Radiopharmaceuticals
  3. 4.1.2 Therapeutic Radiopharmaceuticals
  4. 4.2 Global SPECT and PET Radiopharmaceuticals Sales by Type
  5. 4.2.1 Global SPECT and PET Radiopharmaceuticals Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global SPECT and PET Radiopharmaceuticals Sales by Type (2021-2032)
  7. 4.2.3 Global SPECT and PET Radiopharmaceuticals Sales Market Share by Type (2021-2032)
  8. 4.3 Global SPECT and PET Radiopharmaceuticals Revenue by Type
  9. 4.3.1 Global SPECT and PET Radiopharmaceuticals Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global SPECT and PET Radiopharmaceuticals Revenue by Type (2021-2032)
  11. 4.3.3 Global SPECT and PET Radiopharmaceuticals Revenue Market Share by Type (2021-2032)
5 SPECT and PET Radiopharmaceuticals Market by Application
  1. 5.1 SPECT and PET Radiopharmaceuticals Application Introduction
  2. 5.1.1 Hospitals
  3. 5.1.2 Clinics
  4. 5.1.3 Others
  5. 5.2 Global SPECT and PET Radiopharmaceuticals Sales by Application
  6. 5.2.1 Global SPECT and PET Radiopharmaceuticals Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global SPECT and PET Radiopharmaceuticals Sales by Application (2021-2032)
  8. 5.2.3 Global SPECT and PET Radiopharmaceuticals Sales Market Share by Application (2021-2032)
  9. 5.3 Global SPECT and PET Radiopharmaceuticals Revenue by Application
  10. 5.3.1 Global SPECT and PET Radiopharmaceuticals Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global SPECT and PET Radiopharmaceuticals Revenue by Application (2021-2032)
  12. 5.3.3 Global SPECT and PET Radiopharmaceuticals Revenue Market Share by Application (2021-2032)
6 Global SPECT and PET Radiopharmaceuticals Sales by Region
  1. 6.1 Global SPECT and PET Radiopharmaceuticals Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global SPECT and PET Radiopharmaceuticals Sales by Region (2021-2032)
  3. 6.2.1 Global SPECT and PET Radiopharmaceuticals Sales by Region (2021-2026)
  4. 6.2.2 Global SPECT and PET Radiopharmaceuticals Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America SPECT and PET Radiopharmaceuticals Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America SPECT and PET Radiopharmaceuticals Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe SPECT and PET Radiopharmaceuticals Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe SPECT and PET Radiopharmaceuticals Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific SPECT and PET Radiopharmaceuticals Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific SPECT and PET Radiopharmaceuticals Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa SPECT and PET Radiopharmaceuticals Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa SPECT and PET Radiopharmaceuticals Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global SPECT and PET Radiopharmaceuticals Revenue by Region
  1. 7.1 Global SPECT and PET Radiopharmaceuticals Revenue by Region
  2. 7.1.1 Global SPECT and PET Radiopharmaceuticals Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global SPECT and PET Radiopharmaceuticals Revenue by Region (2021-2026)
  4. 7.1.3 Global SPECT and PET Radiopharmaceuticals Revenue by Region (2027-2032)
  5. 7.1.4 Global SPECT and PET Radiopharmaceuticals Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America SPECT and PET Radiopharmaceuticals Revenue (2021-2032)
  8. 7.2.2 North America SPECT and PET Radiopharmaceuticals Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe SPECT and PET Radiopharmaceuticals Revenue (2021-2032)
  11. 7.3.2 Europe SPECT and PET Radiopharmaceuticals Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific SPECT and PET Radiopharmaceuticals Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific SPECT and PET Radiopharmaceuticals Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa SPECT and PET Radiopharmaceuticals Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa SPECT and PET Radiopharmaceuticals Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 China Isotope & Radiation
  2. 8.1.1 China Isotope & Radiation Company Information
  3. 8.1.2 China Isotope & Radiation Business Overview
  4. 8.1.3 China Isotope & Radiation SPECT and PET Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 China Isotope & Radiation SPECT and PET Radiopharmaceuticals Product Portfolio
  6. 8.1.5 China Isotope & Radiation Recent Developments
  7. 8.2 Novartis
  8. 8.2.1 Novartis Company Information
  9. 8.2.2 Novartis Business Overview
  10. 8.2.3 Novartis SPECT and PET Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Novartis SPECT and PET Radiopharmaceuticals Product Portfolio
  12. 8.2.5 Novartis Recent Developments
  13. 8.3 Eli Lilly
  14. 8.3.1 Eli Lilly Company Information
  15. 8.3.2 Eli Lilly Business Overview
  16. 8.3.3 Eli Lilly SPECT and PET Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Eli Lilly SPECT and PET Radiopharmaceuticals Product Portfolio
  18. 8.3.5 Eli Lilly Recent Developments
  19. 8.4 Dongcheng
  20. 8.4.1 Dongcheng Company Information
  21. 8.4.2 Dongcheng Business Overview
  22. 8.4.3 Dongcheng SPECT and PET Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Dongcheng SPECT and PET Radiopharmaceuticals Product Portfolio
  24. 8.4.5 Dongcheng Recent Developments
  25. 8.5 Bayer
  26. 8.5.1 Bayer Company Information
  27. 8.5.2 Bayer Business Overview
  28. 8.5.3 Bayer SPECT and PET Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Bayer SPECT and PET Radiopharmaceuticals Product Portfolio
  30. 8.5.5 Bayer Recent Developments
  31. 8.6 SIEMENS
  32. 8.6.1 SIEMENS Company Information
  33. 8.6.2 SIEMENS Business Overview
  34. 8.6.3 SIEMENS SPECT and PET Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 SIEMENS SPECT and PET Radiopharmaceuticals Product Portfolio
  36. 8.6.5 SIEMENS Recent Developments
  37. 8.7 Mundipharma
  38. 8.7.1 Mundipharma Company Information
  39. 8.7.2 Mundipharma Business Overview
  40. 8.7.3 Mundipharma SPECT and PET Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Mundipharma SPECT and PET Radiopharmaceuticals Product Portfolio
  42. 8.7.5 Mundipharma Recent Developments
  43. 8.8 Lantheus
  44. 8.8.1 Lantheus Company Information
  45. 8.8.2 Lantheus Business Overview
  46. 8.8.3 Lantheus SPECT and PET Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Lantheus SPECT and PET Radiopharmaceuticals Product Portfolio
  48. 8.8.5 Lantheus Recent Developments
  49. 8.9 Jubilant Pharma
  50. 8.9.1 Jubilant Pharma Company Information
  51. 8.9.2 Jubilant Pharma Business Overview
  52. 8.9.3 Jubilant Pharma SPECT and PET Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Jubilant Pharma SPECT and PET Radiopharmaceuticals Product Portfolio
  54. 8.9.5 Jubilant Pharma Recent Developments
  55. 8.10 GE Healthcare
  56. 8.10.1 GE Healthcare Company Information
  57. 8.10.2 GE Healthcare Business Overview
  58. 8.10.3 GE Healthcare SPECT and PET Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 GE Healthcare SPECT and PET Radiopharmaceuticals Product Portfolio
  60. 8.10.5 GE Healthcare Recent Developments
  61. 8.11 Curium Pharma
  62. 8.11.1 Curium Pharma Company Information
  63. 8.11.2 Curium Pharma Business Overview
  64. 8.11.3 Curium Pharma SPECT and PET Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Curium Pharma SPECT and PET Radiopharmaceuticals Product Portfolio
  66. 8.11.5 Curium Pharma Recent Developments
  67. 8.12 Cardinal Health
  68. 8.12.1 Cardinal Health Company Information
  69. 8.12.2 Cardinal Health Business Overview
  70. 8.12.3 Cardinal Health SPECT and PET Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Cardinal Health SPECT and PET Radiopharmaceuticals Product Portfolio
  72. 8.12.5 Cardinal Health Recent Developments
  73. 8.13 Bracco Imaging
  74. 8.13.1 Bracco Imaging Company Information
  75. 8.13.2 Bracco Imaging Business Overview
  76. 8.13.3 Bracco Imaging SPECT and PET Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Bracco Imaging SPECT and PET Radiopharmaceuticals Product Portfolio
  78. 8.13.5 Bracco Imaging Recent Developments
  79. 8.14 Aurobindo Pharma
  80. 8.14.1 Aurobindo Pharma Company Information
  81. 8.14.2 Aurobindo Pharma Business Overview
  82. 8.14.3 Aurobindo Pharma SPECT and PET Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Aurobindo Pharma SPECT and PET Radiopharmaceuticals Product Portfolio
  84. 8.14.5 Aurobindo Pharma Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 SPECT and PET Radiopharmaceuticals Value Chain Analysis
  2. 9.1.1 SPECT and PET Radiopharmaceuticals Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 SPECT and PET Radiopharmaceuticals Production Mode & Process
  6. 9.2 SPECT and PET Radiopharmaceuticals Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 SPECT and PET Radiopharmaceuticals Distributors
  9. 9.2.3 SPECT and PET Radiopharmaceuticals Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst